Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 20/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL508678 | 0.89 | PDE4D (0.45) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL508679 | 0.86 | PDE4D (0.46) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL508147 | 0.85 | PDE4D (0.58) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL16435086 | 0.85 | PDE4D (0.73) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL509437 | 0.83 | PDE4D (0.44) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL3469295 | 0.83 | PDE4D (0.76) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL7925787 | 0.83 | PDE4D (0.48) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL3469538 | 0.82 | PDE4D (0.45) | PDE4DPDE4A | |
| SCHEMBL17571372 | 0.81 | PDE4D (0.39) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL509452 | 0.80 | PDE4D (0.70) | PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379548-B1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA AS (DK) | 2016-03-09 | — | — | EP | claimed |
| US-8952162-B2 | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases | LEO PHARMA A/S (DK) | 2015-02-10 | — | — | US | claimed |
| WO-2010069322-A1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA A/S (DK) | 2010-06-24 | — | — | WO | claimed |
| EP-2379548-B1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA AS (DK) | 2016-03-09 | — | — | EP | disclosed |
| US-8952162-B2 | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases | LEO PHARMA A/S (DK) | 2015-02-10 | — | — | US | disclosed |
| WO-2010069322-A1 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES | LEO PHARMA A/S (DK) | 2010-06-24 | — | — | WO | disclosed |